In summary, QSYQ inhibits NLRP3 inflammatory vesicles and inflammatory signaling pathways such as TGFβ1/Smads, STAT3, and NF-κB, and has multi-target anti-myocardial fibrosis properties. Here, NLRP3 is linked to Myocardial fibrosis.